Oxidative phosphorylation diseases and cerebellar ataxia

J M Shoffner1, A Kaufman, D Koontz

  • 1Department of Genetics and Molecular Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Clinical Neuroscience (New York, N.Y.)
|January 1, 1995
PubMed

Insights

Mitochondrial DNA (mtDNA) mutations, including rearrangements and point mutations, can cause oxidative phosphorylation (OXPHOS) diseases. This review details OXPHOS disorders linked to mtDNA mutations where cerebellar ataxia is a prominent symptom.

Area of Science:

  • Genetics
  • Biochemistry
  • Neurology

Background:

  • Oxidative phosphorylation (OXPHOS) diseases arise from genetic defects in nuclear or mitochondrial DNA (mtDNA).
  • mtDNA mutations encompass large rearrangements (deletions/duplications) and point mutations in tRNA, rRNA, or OXPHOS polypeptide genes.
  • While numerous mtDNA mutations exist, only a subset are linked to cerebellar ataxia.

Purpose of the Study:

  • To review the clinical, biochemical, and genetic characteristics of OXPHOS diseases.
  • To focus on OXPHOS disorders caused by mtDNA mutations presenting with cerebellar ataxia.

Main Methods:

  • Literature review of genetic mutations affecting OXPHOS.
  • Analysis of clinical, biochemical, and genetic data from relevant studies.
  • Synthesis of information on mtDNA mutations associated with cerebellar ataxia.

Main Results:

  • Over 30 pathogenic mtDNA point mutations and 60+ mtDNA deletion types are documented.
  • A specific subset of these mtDNA mutations is associated with cerebellar ataxia.
  • Clinical, biochemical, and genetic features vary among these OXPHOS diseases.

Conclusions:

  • mtDNA mutations are a significant cause of OXPHOS diseases with ataxia.
  • Understanding these genetic and clinical features is crucial for diagnosis and management.
  • Further research is needed to elucidate the mechanisms linking specific mtDNA mutations to cerebellar ataxia.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...